Fresenius reported EUR20.42B in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Akzo Nobel AKZA:NA EUR 4.33B 790M
Alcon AG ALC:SW USD 19.68B 30M
AstraZeneca AZN:LN USD 37.04B 1.9B
BASF BAS:GR EUR 39.57B 8.03B
Bayer BAYN:GR EUR 38.77B 2.5B
Davita Healthcare Partners DVA:US USD 712.33M 179.65M
E.ON EOAN:GR EUR 15.92B 3.16B
Essilor EI:FP EUR 37.46B 363M
Fresenius FRE:GR EUR 20.42B 967M
Getinge GETIB:SS SEK 30.04B 414M
Givaudan GIVN:VX CHF 4.23B 216M
GlaxoSmithKline GSK:LN GBP 10.6B 1.45B
GN Store Nord GN:DC DKK 6.8B 402M
Hikma Pharmaceutical HIK:LN USD 2.14B 41M
Lonza Group LONN:SW CHF 10.6B 586M
Merck MRK:GR EUR 25.93B 2.33B
Novartis NOVN:VX USD 59.34B 1.48B
Roche Holding ROG:VX 27.99B 2.8B
RWE RWE:GR EUR 27.58B 29.06B
Smith & Nephew PLC SN/:LN 5.4B 173M
William Demant Holding WDH:DC DKK 8.56B 382M